| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.034 | 0.8 |